{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:55:14Z","timestamp":1782345314412,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Outcome measures currently used to assess function in Angelman Syndrome (AS) may be affected by participant anxiety in the clinic, use of a measure outside of age norms, and a reliance on caregiver report. This study aimed to leverage the process used to develop the Duchenne Video Assessment to develop, pilot, and evaluate tasks to be recorded in AS to lay the foundation for the Angelman Syndrome Video Assessment (ASVA), which is being developed for the assessment of everyday functional skills in individuals with AS in their home environment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The task list was informed by published conceptual disease models identifying four domains of interest (i.e. communication, motor skills (fine and gross), self-care and executive functioning) and determined by a team of experts based on family and clinician input. The study was conducted remotely in the home environment, with families capturing videos of everyday activities and participating in an exit interview about their experience. Videos were evaluated, and caregiver interview transcripts were coded and analyzed to determine whether each task would be included in the finalized measure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven dyads (i.e., caregiver and individual with AS) completed the study. Individuals with AS between 4 and 39\u00a0years of age were enrolled. The video completion rate was 96%, with 99% of the submitted videos meeting quality standards. Caregivers endorsed the value of assessing these individuals in their home environment. The video capture list was reduced to 13 tasks for ambulatory individuals and 12 tasks for minimally ambulatory individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The ASVA is a novel tool that captures data on the daily functioning of individuals with AS in their home environment. If it is validated in the future, this tool presents a promising new approach to evaluate participant functioning in clinical trials and for clinical care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11689-026-09676-2","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:07:27Z","timestamp":1771495647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of at-home video recordings for functional skill assessment in Angelman Syndrome: a pilot study"],"prefix":"10.1186","volume":"18","author":[{"given":"Mindy","family":"Leffler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina K.","family":"Zigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Crean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine F.","family":"Merton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Booman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnna D.","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriszha A.","family":"Sheehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Duis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hann","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"9676_CR1","doi-asserted-by":"publisher","unstructured":"Bird L. Angelman syndrome: review of clinical and molecular aspects. Appl Clin Genet. 2014:93. https:\/\/doi.org\/10.2147\/tacg.s57386.","DOI":"10.2147\/tacg.s57386"},{"key":"9676_CR2","unstructured":"Dagli AI, Mathews J, Williams CA. Angelman Syndrome. 1998 Sep 15 [updated 2021 Apr 22]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae\u00a0. Seattle (WA): University of Washington, Seattle; 1993\u20132025. PMID: 20301323."},{"issue":"7","key":"9676_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/DBP.0b013e3181ee408e","volume":"31","author":"JK Gentile","year":"2010","unstructured":"Gentile JK, Tan WH, Horowitz LT, et al. A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations. J Dev Behav Pediatr. 2010;31(7):592\u2013601. https:\/\/doi.org\/10.1097\/DBP.0b013e3181ee408e.","journal-title":"J Dev Behav Pediatr"},{"issue":"7","key":"9676_CR4","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41380-020-0858-6","volume":"26","author":"M Keute","year":"2021","unstructured":"Keute M, Miller MT, Krishnan ML, et al. Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment. Mol Psychiatry. 2021;26(7):3625\u201333. https:\/\/doi.org\/10.1038\/s41380-020-0858-6.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"9676_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ajmg.a.61140","volume":"179","author":"A Sadhwani","year":"2019","unstructured":"Sadhwani A, Willen JM, LaVallee N, et al. Maladaptive behaviors in individuals with Angelman syndrome. Am J Med Genet A. 2019;179(6):983\u201392. https:\/\/doi.org\/10.1002\/ajmg.a.61140.","journal-title":"Am J Med Genet A"},{"key":"9676_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-023-06090-8","author":"A Gwaltney","year":"2023","unstructured":"Gwaltney A, Potter SN, Peters SU, et al. Adaptive skills of individuals with Angelman syndrome assessed using the Vineland Adaptive Behavior Scales, 2nd edition. J Autism Dev Disord. 2023. https:\/\/doi.org\/10.1007\/s10803-023-06090-8.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"9676_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13023-023-02729-y","volume":"18","author":"S Connor-Ahmad","year":"2023","unstructured":"Connor-Ahmad S, Tjeertes J, Chladek M, Newton L, Symonds T, Clinch S, et al. Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development. Orphanet J Rare Dis. 2023;18(1):156.","journal-title":"Orphanet J Rare Dis"},{"issue":"3\u20135","key":"9676_CR8","first-page":"100","volume":"2","author":"A Dagli","year":"2012","unstructured":"Dagli A, Buiting K, Williams CA. Molecular and clinical aspects of angelman syndrome. Mol Syndromol. 2012;2(3\u20135):100\u201312 (000328837).","journal-title":"Mol Syndromol"},{"issue":"10","key":"9676_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/jir.12635","volume":"63","author":"AC Wheeler","year":"2019","unstructured":"Wheeler AC, Okoniewski KC, Wylie A, et al. Anxiety-associated and separation distress-associated behaviours in Angelman syndrome. J Intellect Disabil Res. 2019;63(10):1234\u201347. https:\/\/doi.org\/10.1111\/jir.12635.","journal-title":"J Intellect Disabil Res"},{"key":"9676_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13023-023-02729-y","volume":"18","author":"S Connor-Ahmad","year":"2023","unstructured":"Connor-Ahmad S, Tjeertes J, Chladek M, et al. Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development. Orphanet J Rare Dis. 2023;18:156. https:\/\/doi.org\/10.1186\/s13023-023-02729-y.","journal-title":"Orphanet J Rare Dis"},{"key":"9676_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-021-05238-8","author":"CJ Keary","year":"2021","unstructured":"Keary CJ, Mullett JE, Nowinski L, et al. Parent description of anxiety in Angelman syndrome. J Autism Dev Disord. 2021. https:\/\/doi.org\/10.1007\/s10803-021-05238-8.","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"9676_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ajmg.a.36864","volume":"167A","author":"AM Larson","year":"2015","unstructured":"Larson AM, Shinnick JE, Shaaya EA, Thiele EA, Thibert RL. Angelman syndrome in adulthood. Am J Med Genet A. 2015;167A(2):331\u201344. https:\/\/doi.org\/10.1002\/ajmg.a.36864.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"9676_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ajmg.a.30065","volume":"128A","author":"SU Peters","year":"2004","unstructured":"Peters SU, Goddard-Finegold J, Beaudet AL, Madduri N, Turcich M, Bacino CA. Cognitive and adaptive behavior profiles of children with Angelman syndrome. Am J Med Genet A. 2004;128A(2):110\u20133. https:\/\/doi.org\/10.1002\/ajmg.a.30065.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"9676_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s11689-023-09494-w","volume":"15","author":"J Tjeertes","year":"2023","unstructured":"Tjeertes J, Bacino CA, Bichell TJ, Bird LM, Bustamante M, Crean R, et al. Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS). J Neurodev Disord. 2023;15(1):22. https:\/\/doi.org\/10.1186\/s11689-023-09494-w.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"9676_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1352\/0047-6765(1997)035","volume":"35","author":"S Voelker","year":"1997","unstructured":"Voelker S, Shore D, Hakim-Larson J, Bruner D. Discrepancies in parent and teacher ratings of adaptive behavior of children with multiple disabilities. Ment Retard. 1997;35(1):10\u20137. https:\/\/doi.org\/10.1352\/0047-6765(1997)035. (PMID: 9046782).","journal-title":"Ment Retard"},{"issue":"6","key":"9676_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/09638280410001658658","volume":"26","author":"J Ogonowski","year":"2004","unstructured":"Ogonowski J, Kronk R, Rice C, Feldman H. Inter-rater reliability in assigning ICF codes to children with disabilities. Disabil Rehabil. 2004;26(6):353\u201361. https:\/\/doi.org\/10.1080\/09638280410001658658. (PMID: 15204487).","journal-title":"Disabil Rehabil"},{"issue":"1","key":"9676_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jcomdis.2006.06.001","volume":"40","author":"NE Hall","year":"2007","unstructured":"Hall NE, Segarra VR. Predicting academic performance in children with language impairment: the role of parent report. J Commun Disord. 2007;40(1):82\u201395. https:\/\/doi.org\/10.1016\/j.jcomdis.2006.06.001. (Epub 2006 Jul 31. PMID: 16876817).","journal-title":"J Commun Disord"},{"issue":"8","key":"9676_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jaac.2011.03.012","volume":"50","author":"S Ozonoff","year":"2011","unstructured":"Ozonoff S, Iosif A-M, Young GS, et al. Onset patterns in Autism: correspondence between home video and parent report. J Am Acad Child Adolesc Psychiatry. 2011;50(8):796-806.e1. https:\/\/doi.org\/10.1016\/j.jaac.2011.03.012.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"9676_CR19","doi-asserted-by":"publisher","first-page":"e1993","DOI":"10.1002\/pri.1993","volume":"28","author":"MG Contesse","year":"2023","unstructured":"Contesse MG, Hodges J, Staunton H, et al. Home-based video assessment of ease of movement for patients with Duchenne: Interviews with physical therapists to select movement tasks. Physiother Res Int. 2023;28:e1993.","journal-title":"Physiother Res Int"},{"issue":"4","key":"9676_CR20","doi-asserted-by":"publisher","first-page":"e0266845","DOI":"10.1371\/journal.pone.0266845","volume":"17","author":"MG Contesse","year":"2022","unstructured":"Contesse MG, Lowes LP, White MK, et al. Development of Duchenne video assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS ONE. 2022;17(4):e0266845. https:\/\/doi.org\/10.1371\/journal.pone.0266845.","journal-title":"PLoS ONE"},{"issue":"2","key":"9676_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mus.27335","volume":"64","author":"MG Contesse","year":"2021","unstructured":"Contesse MG, Sapp ATL, Apkon SD, Lowes LP, Dalle Pazze L, Leffler MG. Reliability and construct validity of the Duchenne video assessment. Muscle Nerve. 2021;64(2):180\u20139. https:\/\/doi.org\/10.1002\/mus.27335.","journal-title":"Muscle Nerve"},{"issue":"11","key":"9676_CR22","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s11136-019-02245-2","volume":"28","author":"MK White","year":"2019","unstructured":"White MK, Leffler M, Rychlec K, et al. Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD). Qual Life Res. 2019;28(11):2979\u201388. https:\/\/doi.org\/10.1007\/s11136-019-02245-2.","journal-title":"Qual Life Res"},{"key":"9676_CR23","unstructured":"US Food and Drug Administration, Patient-Focused Drug Development Framework. Retrieved May 13th, 2025 from https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical."},{"issue":"1","key":"9676_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40271-018-0323-7","volume":"12","author":"JC Grieco","year":"2019","unstructured":"Grieco JC, Romero B, Flood E, Cabo R, Visootsak J. A conceptual model of Angelman syndrome and review of relevant clinical outcomes assessments (COAs). Patient. 2019;12(1):97\u2013112. https:\/\/doi.org\/10.1007\/s40271-018-0323-7. (PMID: 29987743; PMCID: PMC6335381).","journal-title":"Patient"},{"issue":"4","key":"9676_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s10578-020-01051-z","volume":"52","author":"T Willgoss","year":"2021","unstructured":"Willgoss T, Cassater D, Connor S, Krishnan ML, Miller MT, Dias-Barbosa C, et al. Measuring what matters to individuals with Angelman syndrome and their families: development of a patient-centered disease concept model. Child Psychiatry Hum Dev. 2021;52(4):654\u201368. https:\/\/doi.org\/10.1007\/s10578-020-01051-z. (PMID: 32880036; PMCID: PMC8238699).","journal-title":"Child Psychiatry Hum Dev"},{"issue":"1","key":"9676_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12883-014-0232-x","volume":"14","author":"JC Grieco","year":"2014","unstructured":"Grieco JC, Ciarlone SL, Gieron-Korthals M, Schoenberg MR, Smith AG, Philpot RM, et al. An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome. BMC Neurol. 2014;14(1):232. https:\/\/doi.org\/10.1186\/s12883-014-0232-x. (PMID: 25491305; PMCID: PMC4276108).","journal-title":"BMC Neurol"},{"issue":"1","key":"9676_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13023-018-0891-6","volume":"13","author":"B Ruiz-Antoran","year":"2018","unstructured":"Ruiz-Antoran B, Sancho-L\u00f3pez A, Cazorla-Calleja R, L\u00f3pez-P\u00e1jaro LF, Leiva \u00c1, Iglesias-Escalera G, et al. A randomized placebo controlled clinical trial to evaluate the efficacy and safety of minocycline in patients with Angelman syndrome (A-MANECE study). Orphanet J Rare Dis. 2018;13(1):144. https:\/\/doi.org\/10.1186\/s13023-018-0891-6. (PMID: 30126448; PMCID: PMC6102900).","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"9676_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-023-02693-7","volume":"18","author":"M Ghadessi","year":"2023","unstructured":"Ghadessi M, Di J, Wang C, Toyoizumi K, Shao N, Mei C, et al. Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective. Orphanet J Rare Dis. 2023;18(1):79. https:\/\/doi.org\/10.1186\/s13023-023-02693-7. (PMID: 37041605; PMCID: PMC10088572).","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"9676_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s43441-024-00615-8","volume":"58","author":"R Izem","year":"2024","unstructured":"Izem R, Zuber E, Daizadeh N, Bretz F, Sverdlov O, Edrich P, et al. Decentralized clinical trials: scientific considerations through the lens of the estimand framework. Ther Innov Regul Sci. 2024;58(3):495\u2013504. https:\/\/doi.org\/10.1007\/s43441-024-00615-8. (Epub 2024 Feb 5. PMID: 38315407).","journal-title":"Ther Innov Regul Sci"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-026-09676-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-026-09676-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-026-09676-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:28:49Z","timestamp":1781634529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11689-026-09676-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9676"],"URL":"https:\/\/doi.org\/10.1186\/s11689-026-09676-2","relation":{},"ISSN":["1866-1955"],"issn-type":[{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from IntegReview, a central Institutional Review Board, and the study was performed in accordance with the ethical standards as laid out in the 1964 Declaration of Helsinki and its later amendments. Approval number CAS-CAS004-01, approved December 31, 2020. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}